DreaMed Diabetes, the Petah Tikva-based developer of personalized diabetes management solutions, has received US Food and Drug Administration (FDA) clearance for its artificial intelligence-powered insulin recommendations technology.
Read more here.
![[The EVERY Company in Green Queen] The Every Company raises $175m to crack open the precision fermentation egg market](https://blog.mktg.ocdvlp.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[The EVERY Company in Green Queen] The Every Company raises $175m to crack open the precision fermentation egg market
December 8, 2021
[Sight Diagnostics in The Jerusalem Post] Israeli startup to process blood test in ten minutes cleared by US FDA
December 5, 2019
